Do type 1 receptor tyrosine kinases inform treatment choice? A prospectively planned analysis of the TEAM trial.
Bartlett, J M S
Do type 1 receptor tyrosine kinases inform treatment choice? A prospectively planned analysis of the TEAM trial. [electronic resource] - British journal of cancer Oct 2013 - 2453-61 p. digital
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
1532-1827
10.1038/bjc.2013.609 doi
Adult
Aged
Aged, 80 and over
Androstadienes--therapeutic use
Aromatase Inhibitors--therapeutic use
Biomarkers, Tumor--metabolism
Breast Neoplasms--drug therapy
Disease-Free Survival
ErbB Receptors--metabolism
Female
Humans
Middle Aged
Molecular Sequence Data
Prognosis
Prospective Studies
Receptors, Estrogen--metabolism
Receptors, Progesterone--metabolism
Selective Estrogen Receptor Modulators--therapeutic use
Tamoxifen--therapeutic use
Tissue Array Analysis
Do type 1 receptor tyrosine kinases inform treatment choice? A prospectively planned analysis of the TEAM trial. [electronic resource] - British journal of cancer Oct 2013 - 2453-61 p. digital
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
1532-1827
10.1038/bjc.2013.609 doi
Adult
Aged
Aged, 80 and over
Androstadienes--therapeutic use
Aromatase Inhibitors--therapeutic use
Biomarkers, Tumor--metabolism
Breast Neoplasms--drug therapy
Disease-Free Survival
ErbB Receptors--metabolism
Female
Humans
Middle Aged
Molecular Sequence Data
Prognosis
Prospective Studies
Receptors, Estrogen--metabolism
Receptors, Progesterone--metabolism
Selective Estrogen Receptor Modulators--therapeutic use
Tamoxifen--therapeutic use
Tissue Array Analysis